Skip to main content

Animations

MJFF Publications

6651 - 6660 of 8785 Results
Title
Year
  • Year
  • 2018
  • 2025
  • 2024
  • 2016
  • 2017
  • 2025
  • 2016
  • 2019
  • 2015
  • 2022
  • Summary Details
    OPEN
    Title: α-Synuclein fibril-induced paradoxical structural and functional defects in hippocampal neurons
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-018-0537-x
    Citation Count: 83
  • Summary Details
    OPEN
    Title: Quantitative 3D histochemistry reveals region-specific amyloid-β reduction by the antidiabetic drug netoglitazone
    Journal Name: PLOS One
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc0
    DOI - Digital Object Identifier: 10.1371/journal.pone.0309489
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Association of Specific Leg Muscle Strength and Motor Features in Parkinson’s Disease
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2024/5580870
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Neuropsychological impairment in prodromal Parkinson's disease
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2016.10.007
    Citation Count: 14
  • Summary Details
    RESTRICTED
    Title: Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p4.007
    Citation Count: 0
  • Summary Details
    OPEN
    Title: 3D imaging of neuronal inclusions and protein aggregates in human neurodegeneration by multiscale x‐ray phase‐contrast tomography
    Journal Name: Brain Pathology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/bpa.70044
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0153564
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: NILO-PD: A Phase 2A Study of Nilotinib in Patients with Advanced and Early Parkinson’s Disease: Study Design and Status Update (P3.8-035)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p3.8-035
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Unawareness of Hyposmia in Elderly People With and Without Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12220
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson’s disease
    Journal Name: Molecular Therapy - Nucleic Acids
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.omtn.2022.02.007
    Citation Count: 20
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.